in a 24-week multicenter double-blind clinical trial , efficacy and safety of the novel nonsteroidal anti-inflammatory drug imidazole salicylate ( 750 mg t.i.d . per os ) and ibuprofen ( 600 mg t.i.d . per os ) were compared in 60 patients with classical or definite rheumatoid arthritis , randomly assigned to one of the two treatment groups .
C0020740
ibuprofen
C0003873
rheumatoid arthritis